Improved metabolic and immune regulation may play a role
usually improves over several weeks Diarrhoea or constipation : Altered bowel habits due to delayed gastric emptying Abdominal discomfort : Bloating, dyspepsia, or gastro-oesophageal reflux symptoms Practical management strategies recommended by NICE and specialist diabetes services include: Starting at the lowest licensed dose and titrating gradually according to the product's summary of product characteristics Eating smaller, more frequent meals and avoiding high-fat foods Maintaining adequate hydration, particularly if experiencing vomiting or diarrhoea Taking the injection at a consistent time as specified in the SmPC for your particular medication Less common but important adverse effects include: Injection site reactions : Rotate injection sites systematically between abdomen, thigh, and upper arm to minimise localised reactions Hypoglycaemia : Risk increases when GLP-1 agents are combined with insulin or sulphonylureas
A 2016 meta-analysis examined 28 randomized controlled trials covering 29,018 people with overweight or obesity
Over time, newer agents improved both convenience and effectiveness
Achieving sustainable, long-term sobriety is the ultimate goal in addiction recovery
[DOI] [PubMed] [Google Scholar] 27.Jin T
.webp)
